Incremental Dialysis Decision Model Based on Expert-Guided Machine Learning
Machine Learning Based on Expert Knowledge to Build and Validate a Decision Model for Incremental Dialysis
Machine Learning Based on Expert Knowledge to Build and Validate a Decision Model for Incremental Dialysis
Sponsor study identifier
observational
175
1 country
1
Study Start
April 12, 2010
Actual (reported)Primary Completion
June 28, 2024
Actual (reported)Study Completion
June 28, 2024
Actual (reported)This observational prospective study combined clinical expert knowledge with machine learning to develop and validate a predictive model for incremental hemodialysis decision-making. The aim of the predictive model is to assist clinicians in developing individualized incremental dialysis treatment plans to optimize patient outcomes.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 28, 2024
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 12, 2010
Actual (reported)June 28, 2024
Actual (reported)June 28, 2024
Actual (reported)January 5, 2025
Actual (reported)January 14, 2025
Actual (reported)Number (Proportion) of Participants Who Experience an Incremental Dialysis Event, Assessed Monthly
An incremental dialysis event is defined as an increase in a patient's dialysis frequency (e.g., from 1 session per week to 2 sessions per week, or from 2 to 3 sessions per week, etc.) due to clinical considerations such as decreased residual renal function, fluid overload, or other physician-determined criteria. At each monthly visit (up to 5 years from enrollment), investigators will record whether each participant experiences an incremental event. We will quantify the primary outcome as the number and proportion of participants who transition to a higher dialysis frequency per month, as well as the cumulative incidence over time.
Baseline and monthly visits from enrollment until incremental dialysis event, death, transfer, or up to 5 years (whichever occurs first)
This is a single-center prospective cohort study that included 175 patients with end-stage renal disease (ESKD) who received maintenance hemodialysis at the hemodialysis center of Huashan Hospital from April 2010 to June 2024. The ESKD patient population was comprised of 175 cases in total. All patients retained some residual kidney function (RKF), and their dialysis records and regular laboratory test results were integrated as input features for the machine learning model. The primary objective of the model was twofold: first, to integrate expert knowledge with machine learning to predict when a switch from lower frequency incremental dialysis (I-HD) to higher frequency dialysis should be made; and second, to identify key variables affecting the risk of adverse outcomes over a two-year period.
Hemodialysis patients with residual renal function admitted to dialysis centers
Huashan hospital, Fudan university
Shanghai, Shanghai Municipality, 200040, China
Jing Chen
Huashan Hospital
175 participants (actual enrollment reported by the registry).
First Submitted
January 5, 2025
First Posted
January 14, 2025
Study Start
April 12, 2010
Actual (reported)A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients
Contact the study team to confirm eligibility.
Primary Completion
June 28, 2024
Actual (reported)Study Completion
June 28, 2024
Actual (reported)Last Updated
January 14, 2025
Record last verified: 2025-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: